Company profile for Blackstone Life Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Blackstone Life Sciences (BXLS) fills a critical void in the industry. While life sciences is seeing unprecedented innovation driven by rapid advancements in science and technology, it often lacks the necessary funding to bring medicines and healthcare technologies to market. We work in partnership with the pharmaceutical, biotechnology and medical technology industries to help meet this need. In 2018, Blackstone acquired Clar...
Blackstone Life Sciences (BXLS) fills a critical void in the industry. While life sciences is seeing unprecedented innovation driven by rapid advancements in science and technology, it often lacks the necessary funding to bring medicines and healthcare technologies to market. We work in partnership with the pharmaceutical, biotechnology and medical technology industries to help meet this need. In 2018, Blackstone acquired Clarus, a leading global life sciences firm. Blackstone Life Sciences combines Clarus’ scientific and clinical development expertise with Blackstone’s knowledge and global network, access to capital, resources etc.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
345 Park Ave, New York, NY 10154
Telephone
Telephone
+1 646-313-6590
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251104511714/en/Merck-Enters-into-Research-and-Development-Funding-Agreement-with-Blackstone-Life-Sciences-for-Sacituzumab-Tirumotecan-sac-TMT

BUSINESSWIRE
07 Nov 2025

https://www.globenewswire.com/news-release/2025/08/06/3128218/29517/en/MannKind-and-Blackstone-Announce-up-to-500-Million-Strategic-Financing-Agreement.html

GLOBENEWSWIRE
06 Aug 2025

https://www.businesswire.com/news/home/20250714185639/en/Uniquity-Bio-Welcomes-Will-Kane-as-President-and-CEO

BUSINESSWIRE
14 Jul 2025

https://www.biospace.com/deals/epilepsy-biotech-nabs-up-to-570m-in-deal-with-italys-angelini-plus-140m-fundraising

BIOSPACE
28 May 2025

https://www.prnewswire.com/news-releases/grin-therapeutics-and-angelini-pharma-enter-into-exclusive-collaboration-to-develop-and-commercialize-radiprodil-outside-north-america-302464677.html

PR NEWSWIRE
27 May 2025

https://www.businesswire.com/news/home/20250403148958/en/Blackstone-Life-Sciences-and-Anthos-Therapeutics-Announce-Novartis-has-Completed-the-Acquisition-of-Anthos-Therapeutics-in-a-Deal-Valued-at-up-to-%243.1B-with-%24925M-Paid-Upfront

BUSINESSWIRE
03 Apr 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty